Occurrence and fate of psychiatric pharmaceuticals in the urban water system of Shanghai, China

Chemosphere

Volumn 138, Issue , 2015, Pages 486-493

  Wu, Minghong ^a   Xiang, Jiajia ^a   Que, Chenjing ^a   Chen, Fenfen ^a   Xu, Gang ^a  

^a SHANGHAI UNIVERSITY   (China)

Author keywords

Drinking water; Psychiatric pharmaceuticals; Surface water; Waste water

Indexed keywords

AMIDES; EFFLUENTS; METABOLITES; POTABLE WATER; WASTEWATER; WASTEWATER TREATMENT; WATER POLLUTION;

ACTIVE SUBSTANCE; AQUATIC SYSTEM; BENZODIAZEPINES; SHANGHAI , CHINA; TARGET ANALYTES; TRACE POLLUTANT; URBAN WATER SYSTEMS; WASTEWATER TREATMENT PLANTS;

SURFACE WATERS;

ALPRAZOLAM; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; DIAZEPAM; DOXEPIN; DRINKING WATER; FLUOXETINE; LORAZEPAM; NORDAZEPAM; OXAZEPAM; PSYCHOTROPIC AGENT; SURFACE WATER; TEMAZEPAM; WASTE WATER; WATER; WATER POLLUTANT;

CONCENTRATION (COMPOSITION); DRINKING WATER; DRUG; EFFICIENCY MEASUREMENT; ENVIRONMENTAL FATE; METABOLITE; ORGANIC POLLUTANT; POLLUTANT REMOVAL; POLLUTANT SOURCE; POLLUTION MONITORING; SURFACE WATER; URBAN AREA; WASTE FACILITY; WASTEWATER; WATER POLLUTION;

ARTICLE; ATMOSPHERIC DEPOSITION; CHINA; DESORPTION; EFFLUENT; ENVIRONMENTAL IMPACT; HYDROLYSIS; LIQUID CHROMATOGRAPHY; PARTICULATE MATTER; RURAL AREA; TANDEM MASS SPECTROMETRY; URBAN WATER SYSTEM; WASTE WATER TREATMENT PLANT; WATER CONTAMINATION; WATER SUPPLY; ANALYSIS; CHEMISTRY; CITY; ENVIRONMENTAL MONITORING; WASTE WATER; WATER MANAGEMENT; WATER POLLUTANT;

CHINA; HUANGPU; SHANGHAI;

CHINA; CITIES; ENVIRONMENTAL MONITORING; PSYCHOTROPIC DRUGS; WASTE WATER; WATER; WATER POLLUTANTS, CHEMICAL; WATER PURIFICATION;

EID: 84940923044     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2015.07.002     Document Type: Article

References (36)

1. Baker D.R., Kasprzyk-Hordern B. Multi-residue analysis of drugs of abuse in wastewater and surface water by solid-phase extraction and liquid chromatography-positive electrospray ionisation tandem mass spectrometry. J. Chromatogr. A 2011, 1218:1620-1631.
2. Brooks B.W., Foran C.M., Richards S.M., Weston J., Turner P.K., Stanley J.K., Solomon K.R., Slattery M., La Point T.W. Aquatic ecotoxicology of fluoxetine. Toxicol. Lett. 2003, 142:169-183.
3. Bueno M., Aguera A., Gomez M.J., Hernando M.D., Garcia-Reyes J.F., Fernandez-Alba A.R. Application of liquid chromatography/quadrupole-linear ion trap mass spectrometry and time-of-flight mass spectrometry to the determination of pharmaceuticals and related contaminants in wastewater. Anal. Chem. 2007, 79:9372-9384.
4. Calisto V., Domingues M., Esteves V.I. Photodegradation of psychiatric pharmaceuticals in aquatic environments - kinetics and photodegradation products. Water Res. 2011, 45:6097-6106.
5. Calisto V., Esteves V.I. Psychiatric pharmaceuticals in the environment. Chemosphere 2009, 77:1257-1274.
6. Carmona E., Andreu V., Pico Y. Occurrence of acidic pharmaceuticals and personal care products in Tuna River Basin: from waste to drinking water. Sci. Total Environ. 2014, 484:53-63.
7. Castiglioni S., Zuccato E., Crisci E., Chiabrando C., Fanelli R., Bagnati R. Identification and measurement of illicit drugs and their metabolites in urban wastewater by liquid chromatography-tandem mass spectrometry. Anal. Chem. 2006, 78:8421-8429.
8. Dai G.H., Huang J., Chen W.W., Wang B., Yu G., Deng S.B. Major pharmaceuticals and personal care products (PPCPs) in wastewater treatment plant and receiving water in Beijing, China, and associated ecological risks. B Environ. Contam. Toxicol. 2014, 92:655-661.
9. de Voogt P., Janex-Habibi M.L., Sacher F., Puijker L., Mons M. Development of a common priority list of pharmaceuticals relevant for the water cycle. Water Sci. Technol. 2009, 59(1):39-46.
10. Gros M., Petrovic M., Barcelo D. Development of a multi-residue analytical methodology based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters. Talanta 2006, 70:678-690.
11. Hass U., Duennbier U., Massmann G. Occurrence and distribution of psychoactive compounds and their metabolites in the urban water cycle of Berlin (Germany). Water Res. 2012, 46:6013-6022.
12. Heberer T. Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J. Hydrol. 2002, 266:175-189.
13. Jelic A., Gros M., Ginebreda A., Cespedes-Sanchez R., Ventura F., Petrovic M., Barcelo D. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Res. 2011, 45:1165-1176.
14. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36:1202-1211.
15. Kosma C.I., Lambropoulou D.A., Albanis T.A. Investigation of PPCPs in wastewater treatment plants in Greece: occurrence, removal and environmental risk assessment. Sci. Total Environ. 2014, 466:421-438.
16. Kostich M.S., Batt A.L., Lazorchak J.M. Concentrations of prioritized pharmaceuticals in effluents from 50 large wastewater treatment plants in the US and implications for risk estimation. Environ. Pollut. 2014, 184:354-359.
17. Kummerer K. Significance of antibiotics in the environment. J. Antimicrob. Chemoth. 2003, 52:317. (pg 5).
18. Kuster M., de Alda M.J., Hernando M.D., Petrovic M., Martin-Alonso J., Barcelo D. Analysis and occurrence of pharmaceuticals, estrogens, progestogens and polar pesticides in sewage treatment plant effluents, river water and drinking water in the Llobregat river basin (Barcelona, Spain). J. Hydrol. 2008, 358:112-123.
19. Lajeunesse A., Smyth S.A., Barclay K., Sauve S., Gagnon C. Distribution of antidepressant residues in wastewater and biosolids following different treatment processes by municipal wastewater treatment plants in Canada. Water Res. 2012, 46:5600-5612.
20. Matilainen A., Sillanpaa M. Removal of natural organic matter from drinking water by advanced oxidation processes. Chemosphere 2010, 80:351-365.
21. Mendoza A., de Alda M.L., Gonzalez-Alonso S., Mastroianni N., Barcelo D., Valcarcel Y. Occurrence of drugs of abuse and benzodiazepines in river waters from the Madrid Region (Central Spain). Chemosphere 2014, 95:247-255.
22. Nunes B., Carvalho F., Guilhermino L. Acute toxicity of widely used pharmaceuticals in aquatic species: Gambusia holbrooki, Artemia parthenogenetica and Tetraselmis chuii. Ecotoxicol. Environ. Saf. 2005, 61:413-419.
23. Sanchez-Arguello P., Fernandez C., Tarazona J.V. Assessing the effects of fluoxetine on Physa acuta (Gastropoda, Pulmonata) and Chironomus riparius (Insecta, Diptera) using a two-species water-sediment test. Sci. Total Environ. 2009, 407:1937-1946.
24. Schultzt M.M., Furlong E.T. Trace analysis of antidepressant pharmaceuticals and their select degradates in aquatic matrixes by LC/ESI/MS/MS. Anal. Chem. 2008, 80:1756-1762.
25. Shao B., Chen D., Zhang J., Wu Y.N., Sun C.J. Determination of 76 pharmaceutical drugs by liquid chromatography-tandem mass spectrometry in slaughterhouse wastewater. J. Chromatogr. A 2009, 1216:8312-8318.
26. Snyder S.A. Occurrence, treatment, and toxicological relevance of EDCs and pharmaceuticals in water. Ozone-Sci. Eng. 2008, 30:65-69.
27. Ternes T., Bonerz M., Schmidt T. Determination of neutral pharmaceuticals in wastewater and rivers by liquid chromatography-electrospray tandem mass spectrometry. J. Chromatogr. A 2001, 938:175-185.
28. Togola A., Budzinski H. Multi-residue analysis of pharmaceutical compounds in aqueous samples. J. Chromatogr. A 2008, 1177:150-158.
29. van der Ven K., Keil D., Moens L.N., Van Leemput K., Van Remortelt P., De Coen W.M. Neuropharmaceuticals in the environment: Mianserin-induced neuroendocrine disruption in zebrafish (Danio rerio) using cDNA microarrays. Environ. Toxicol. Chem. 2006, 25:2645-2652.
30. Verplaetse R., Cuypers E., Tytgat J. The evaluation of the applicability of a high pH mobile phase in ultrahigh performance liquid chromatography tandem mass spectrometry analysis of benzodiazepines and benzodiazepine-like hypnotics in urine and blood. J. Chromatogr. A 2012, 1249:147-154.
31. Wang D., Sui Q., Lu S.G., Zhao W.T., Qiu Z.F., Miao Z.W., Yu G. Occurrence and removal of six pharmaceuticals and personal care products in a wastewater treatment plant employing anaerobic/anoxic/aerobic and UV processes in Shanghai, China. Environ. Sci. Pollut. R 2014, 21:4276-4285.
32. West C.E., Rowland S.J. Aqueous phototransformation of diazepam and related human metabolites under simulated sunlight. Environ. Sci. Technol. 2012, 46:4749-4756.
33. Yuan S.L., Jiang X.M., Xia X.H., Zhang H.X., Zheng S.K. Detection, occurrence and fate of 22 psychiatric pharmaceuticals in psychiatric hospital and municipal wastewater treatment plants in Beijing, China. Chemosphere 2013, 90:2520-2525.
34. Zhang H.C., Xu T., Hu X.L., Pang W.H., Yin D.Q. The distributions, removals and estrogenic effects of selected endocrine disrupting chemicals in two drinking water factories in China. J. Water Health 2013, 11:41-50.
35. Zhou X.F., Dai C.M., Zhang Y.L., Surampalli R.Y., Zhang T.C. A preliminary study on the occurrence and behavior of carbamazepine (CBZ) in aquatic environment of Yangtze River Delta, China. Environ. Monit. Assess. 2011, 173:45-53.
36. Zuccato E., Calamari D., Natangelo M., Fanelli R. Presence of therapeutic drugs in the environment. Lancet 2000, 355:1789-1790.